MEDEXUS PHARMACEUTICALS INC (MDP.CA) Forecast, Price Target & Analyst Ratings

TSX:MDP • CA58410Q2036

Current stock price

3.14 CAD
+0.11 (+3.63%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDEXUS PHARMACEUTICALS INC (MDP.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$7.03
+ 123.73% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2026
EPS Estimate
-$0.02
Revenue Estimate
25.842M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$7.03
Upside
+ 123.73%
From current price of CA$3.14 to mean target of CA$7.03, Based on 8 analyst forecasts
Low
CA$5.61
Median
CA$7.14
High
CA$8.40

Price Target Revisions

1 Month
11.09%
3 Months
11.47%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for MDP.CA. The average price target is 7.03 CAD. This implies a price increase of 123.73% is expected in the next year compared to the current price of 3.14.
The average price target has been revised upward by 11.47% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MDP Current Analyst RatingMDP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

MDP Historical Analyst RatingsMDP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
MDP.CA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MDP.CA.
In the previous month the buy percentage consensus was at a similar level.
MDP.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-04-06RAYMOND JAMES LTD.Upgrade Outperform -> Strong Buy
2025-01-06STIFEL CANADAMaintains Buy -> Buy
2022-11-10Raymond James CapitalUpgrade Outperform
2022-10-07Canaccord CapitalUpgrade Hold
2022-09-22Canaccord CapitalDowngrade
2022-09-20Raymond James CapitalDowngrade Market Perform
2022-08-10Stifel Nicolaus ResearchDowngrade
2022-07-26Raymond James CapitalInitiate Outperform
2022-03-02Raymond James CapitalUpgrade Outperform
2022-02-22Raymond James CapitalInitiate Outperform
2022-02-22Raymond James FinancialInitiate Outperform
2021-11-12NationalBankFinancialDowngrade Underperform
2021-08-18Canaccord GenuityDowngrade Hold
2021-03-02Canaccord GenuityUpgrade Hold -> Buy
2021-02-17Canaccord GenuityUpgrade Speculative Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2026
EPS Estimate
-$0.02
Revenue Estimate
25.842M
Revenue Q2Q
4.40%
EPS Q2Q
32.67%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.82%
Revenue (3 Months)
1.21%
EPS (1 Month)
50.00%
EPS (3 Months)
50.00%

Next Earnings Summary

The next earnings revenue estimate has been revised upward by 1.21% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MDP.CA revenue by date.MDP.CA revenue by date.
108.096M
40.93%		113.054M
4.59%		108.332M
-4.18%		101.32M
-6.47%		115.66M
14.15%		139.43M
20.55%		164.68M
18.11%		184.27M
11.90%		213.74M
15.99%		224.7M
5.13%		236.45M
5.23%
EBITDA
YoY % growth
MDP.CA ebitda by date.MDP.CA ebitda by date.
14.57M
333.83%		18.593M
27.61%		19.099M
2.72%		16.034M
-16.05%		22.139M
38.08%		39.918M
80.31%		49.737M
24.60%		58.316M
17.25%		58.928M
1.05%		65.351M
10.90%		72.348M
10.71%
EBIT
YoY % growth
MDP.CA ebit by date.MDP.CA ebit by date.
8.489M
168.59%		12.787M
50.63%		11.921M
-6.77%		4.513M
-62.14%		9.089M
101.40%		25.176M
176.99%		42.005M
66.85%		49.59M
18.06%		53.248M
7.38%		53.552M
0.57%		N/A
Operating Margin
MDP.CA operating margin by date.MDP.CA operating margin by date.
7.85%11.31%11.00%4.45%7.86%18.06%25.51%26.91%24.91%23.83%N/A
EPS
YoY % growth
MDP.CA eps by date.MDP.CA eps by date.
-0.05
96.06%		-0.01
80.00%		0.08
900.00%		-0.01
-112.63%		0.32
3,300.00%		0.73
126.56%		0.65
-11.70%		0.68
4.70%		0.63
-7.47%		0.60
-4.85%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27
EPS
Q2Q % growth		-0.02
32.67%		0.07
253.50%		0.15
1,615.00%
Revenue
Q2Q % growth		25.842M
4.40%		26.866M
9.14%		31.058M
25.53%
EBITDA
Q2Q % growth		3.489M
-49.35%		3.838M
17.16%		6.565M
0.89%
EBIT
Q2Q % growth		572.67K
297.47%		808K
-4.94%		5.05M
205.51%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MDP.CA Yearly Revenue VS EstimatesMDP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M
MDP.CA Yearly EPS VS EstimatesMDP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
109.18%
EPS Next 5 Year
53.29%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.11%
Revenue Next 5 Year
10.80%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
62.94%
EBIT Next 5 Year
44.59%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MEDEXUS PHARMACEUTICALS INC / MDP.CA Forecast FAQ

What is the average price target for MEDEXUS PHARMACEUTICALS INC (MDP.CA) stock?

8 analysts have analysed MDP.CA and the average price target is 7.03 CAD. This implies a price increase of 123.73% is expected in the next year compared to the current price of 3.14.

What are the consensus estimates for MEDEXUS PHARMACEUTICALS INC (MDP.CA) next earnings?

The consensus EPS estimate for the next earnings of MEDEXUS PHARMACEUTICALS INC (MDP.CA) is -0.02 CAD and the consensus revenue estimate is 25.84M CAD.

How do analysts rate MEDEXUS PHARMACEUTICALS INC (MDP.CA)?

The consensus rating for MEDEXUS PHARMACEUTICALS INC (MDP.CA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.